Skip to main content
  • Cath Lab Recap: More CRT Software; Bivalirudin Patent Kerfuffle Interventional cardiology news to note

    The patents for bivalirudin (Angiomax) were upheld by a federal court following a prior ruling that they were invalid. Drugmaker the Medicines Company says it is “now considering all … options with respect to Hospira, Mylan, and other generics.”

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details